Participants
SUBCLINICAL HYPOTHYROIDISM
A total of 44 women with subclinical hypothyroidism were included in this double-blind, randomized, placebo-controlled trial. Patients were enrolled at the endocrinology clinic of Tabriz, Iran, from September 2021 to June 2022. The inclusion criteria were females aged 20–65 years old; diagnosed with subclinical hypothyroidism, TSH 5–10 µIU/mL, normal fT